{"id":1116916,"date":"2019-05-20T05:00:00","date_gmt":"2019-05-20T05:00:00","guid":{"rendered":"https:\/\/commonstockwarrants.com\/nanoviricides-files-quarterly-report-for-period-ending-march-31-2019-herpecide-drug-candidate-pre-ind-application-submitted-progressing-towards-clinical-trials-yahoo-finance-2\/"},"modified":"2019-05-20T05:00:00","modified_gmt":"2019-05-20T05:00:00","slug":"nanoviricides-files-quarterly-report-for-period-ending-march-31-2019-herpecide-drug-candidate-pre-ind-application-submitted-progressing-towards-clinical-trials-yahoo-finance","status":"publish","type":"post","link":"https:\/\/juniorminingnews.com\/?p=1116916","title":{"rendered":"NanoViricides Files Quarterly Report for Period Ending March 31, 2019 &#8211; HerpeCide&#x2122; Drug Candidate Pre-IND Application Submitted, Progressing Towards Clinical Trials &#8211; Yahoo Finance"},"content":{"rendered":"<p><a  href=\"https:\/\/finance.yahoo.com\/news\/nanoviricides-files-quarterly-report-period-110000082.html\">NanoViricides Files Quarterly Report for Period Ending March 31, 2019 &#8211; HerpeCide<img decoding=\"async\" src=\"https:\/\/s.w.org\/images\/core\/emoji\/11\/72x72\/2122.png\" alt=\"&#x2122;\" class=\"wp-smiley\" style=\"height: 1em; max-height: 1em;\" \/> Drug Candidate Pre-IND Application Submitted, Progressing Towards Clinical Trials<\/a>  Yahoo Finance<\/p>\n<p>SHELTON, Conn., May 20, 2019 \/PRNewswire\/ &#8212; NanoViricides, Inc. (NYSE MKT: NNVC) (the &#8220;Company&#8221;) a global leader in the development of highly effective &#8230;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NanoViricides Files Quarterly Report for Period Ending March 31, 2019 &ndash; HerpeCide&trade; Drug Candidate Pre-IND Application Submitted, Progressing Towards Clinical Trials Yahoo Finance SHELTON, Conn., May 20, 2019 \/PRNewswire\/ &mdash; NanoViricides, Inc. (NYSE MKT: NNVC) (the &ldquo;Company&rdquo;) a global leader in the development of highly effective &hellip; &hellip; <a href=\"https:\/\/commonstockwarrants.com\/nanoviricides-files-quarterly-report-for-period-ending-march-31-2019-herpecide-drug-candidate-pre-ind-application-submitted-progressing-towards-clinical-trials-yahoo-finance-2\/\">Continue reading <span>&rarr;<\/span><\/a><\/p>\n","protected":false},"author":12,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[372,454],"tags":[],"_links":{"self":[{"href":"https:\/\/juniorminingnews.com\/index.php?rest_route=\/wp\/v2\/posts\/1116916"}],"collection":[{"href":"https:\/\/juniorminingnews.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/juniorminingnews.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/juniorminingnews.com\/index.php?rest_route=\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/juniorminingnews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1116916"}],"version-history":[{"count":1,"href":"https:\/\/juniorminingnews.com\/index.php?rest_route=\/wp\/v2\/posts\/1116916\/revisions"}],"predecessor-version":[{"id":1116917,"href":"https:\/\/juniorminingnews.com\/index.php?rest_route=\/wp\/v2\/posts\/1116916\/revisions\/1116917"}],"wp:attachment":[{"href":"https:\/\/juniorminingnews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1116916"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/juniorminingnews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1116916"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/juniorminingnews.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1116916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}